Semaglutide is a GLP-1 receptor agonist and an FDA-approved medicine (brands include Ozempic and Wegovy).
Semaglutide is FDA-approved and supported by large clinical trials for its approved indications.
Medical & editorial disclaimer. This article is independent reference information, not medical advice. Use any medicine only under the care of a licensed clinician. Peptide Docket is not affiliated with the FDA and does not sell medicines.